Dean Schorno
Director Financiero/CFO en RIGEL PHARMACEUTICALS, INC. .
Fortuna: 443 180 $ al 30/04/2024
Cargos activos de Dean Schorno
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RIGEL PHARMACEUTICALS, INC. | Director Financiero/CFO | 29/05/2018 | - |
Historial de carrera de Dean Schorno
Antiguos cargos conocidos de Dean Schorno.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Director de Operaciones | 17/08/2015 | 01/05/2018 |
Director Financiero/CFO | 17/08/2015 | 01/05/2018 | |
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director Financiero/CFO | 24/06/2014 | 10/08/2015 |
GENOMIC HEALTH, INC. | Director Financiero/CFO | 10/01/2011 | 01/07/2014 |
Contacto de Relaciones con Inversores | 01/07/2003 | 01/07/2014 | |
Public Communications Contact | 01/07/2003 | 01/07/2014 | |
Corporate Officer/Principal | 01/02/2010 | 10/01/2011 |
Formación de Dean Schorno.
University of California, Berkeley | Undergraduate Degree |
Golden Gate University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Director of Finance/CFO | 4 |
Investor Relations Contact | 1 |
Public Communications Contact | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Dean Schorno
- Experiencia